Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms Tumor

PURPOSE: The prognosis of relapsed or refractory pediatric Wilms tumor (WT) is dismal, and new salvage therapies are needed. This study aimed to evaluate the efficacy of the combination of irinotecan and a doxorubicin hydrochloride liposome regimen for relapsed or refractory pediatric WT. PATIENTS A...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Juan, Zhang, Lian, Guo, Lanying, Que, Yi, Zhang, Yu, Sun, Feifei, Zhu, Jia, Lu, Suying, Huang, Junting, Wu, Liuhong, Cai, Ruiqing, Zhen, Zijun, Zeng, Sihui, Zhang, Yizhuo, Sun, Xiaofei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490759/
https://www.ncbi.nlm.nih.gov/pubmed/34621673
http://dx.doi.org/10.3389/fonc.2021.721564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490759/
https://www.ncbi.nlm.nih.gov/pubmed/34621673
http://dx.doi.org/10.3389/fonc.2021.721564

Ejemplares similares